Please login to see this content
Micro-immunotherapy & Genital Human Papillomavirus Infections
Related Articles
- Micro-immunotherapy & Anogenital Human Papillomavirus infections
- Efficacy of 2L®PAPI, a Micro-Immunotherapy Drug, in Patients with High-Risk Papillomavirus Genital Infection
- High Risk Human Papillomavirus genital infections in asymptomatic population: effectiveness of Micro-Immunotherapy
- The Micro-Immunotherapy Medicine 2LPAPI® Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells